Prasterone - Genelabs

Drug Profile

Prasterone - Genelabs

Alternative Names: Anastar; Aslera; Dehydroepiandrosterone - Genelabs; DHEA - Genelabs; E 10; GL 701; Prestara

Latest Information Update: 19 Jan 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Stanford University
  • Developer Genelabs Technologies
  • Class Androstenols; Hormonal replacements; Small molecules
  • Mechanism of Action Dehydroepiandrosterone-replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Systemic lupus erythematosus
  • New Molecular Entity No

Highest Development Phases

  • No development reported Systemic lupus erythematosus

Most Recent Events

  • 05 Aug 2010 No development reported - Phase-III for Systemic lupus erythematosus in USA (PO)
  • 05 Aug 2010 No development reported - Preregistration for Systemic lupus erythematosus in Europe (PO)
  • 07 Jan 2009 Genelabs Technologies has been acquired by GlaxoSmithKline
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top